Related Experiment Video
Updated: Apr 12, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Transforming growth factor β and bone morphogenetic protein actions in brain tumors
Laia Caja1, Claudia Bellomo1, Aristidis Moustakas1
1Department of Medical Biochemistry and Microbiology, Science for Life Laboratory, Uppsala University, Box 582, SE-751 23 Uppsala, Sweden; Ludwig Cancer Research, Science for Life Laboratory, Uppsala University, Box 595, SE-751 24 Uppsala, Sweden.
Abstract:
Members of the transforming growth factor β (TGF-β) family are implicated in the biology of several cancers. Here we focus on malignancies of the brain and examine the TGFβ and the bone morphogenetic protein (BMP) signaling branches of the family. These pathways exhibit context-dependent actions during tumorigenesis, acting either as tumor suppressors or as pro-tumorigenic agents. In the brain, the TGF-βs associate with oncogenic development and progression to the more malignant state. Inversely, the BMPs suppress tumorigenic potential by acting as agents that induce tumor cell differentiation. The latter has been best demonstrated in grade IV astrocytomas, otherwise known as glioblastoma multiforme. We discuss how the actions of TGF-βs and BMPs on cancer stem cells may explain their effects on tumor progression, and try to highlight intricate mechanisms that may link tumor cell differentiation to invasion. The focus on TGF-β and BMP and their actions in brain malignancies provides a rich territory for mechanistic understanding of tumor heterogeneity and suggests ways for improved therapeutic intervention, currently being addressed by clinical trials.
Insights
Transforming growth factor-β (TGF-β) and bone morphogenetic protein (BMP) signaling pathways have opposing roles in brain cancers. TGF-β promotes malignancy, while BMPs suppress it by inducing tumor cell differentiation.
Area of Science:
- Oncology
- Molecular Biology
- Neuroscience
Background:
- Transforming growth factor-β (TGF-β) family members are involved in various cancers.
- The TGF-β and bone morphogenetic protein (BMP) signaling pathways have context-dependent roles in tumorigenesis, acting as either tumor suppressors or promoters.
- In brain malignancies, TGF-β signaling is linked to oncogenic development and progression.
Purpose of the Study:
- To examine the roles of TGF-β and BMP signaling in brain malignancies.
- To understand how these pathways influence tumor progression and heterogeneity.
- To identify potential therapeutic targets for brain tumors.
Main Methods:
- Review of existing literature on TGF-β and BMP signaling in brain tumors.
- Analysis of the context-dependent actions of these pathways.
- Discussion of the impact on cancer stem cells and tumor cell differentiation.
Main Results:
- TGF-β signaling promotes oncogenic development and progression in brain malignancies.
- BMP signaling acts as a tumor suppressor by inducing differentiation, particularly evident in glioblastoma.
- Mechanisms linking tumor cell differentiation to invasion are explored.
Conclusions:
- TGF-β and BMP signaling pathways play critical, opposing roles in brain tumor biology.
- Understanding these pathways' actions on cancer stem cells is key to explaining tumor progression.
- Targeting TGF-β and BMP signaling offers potential for novel therapeutic strategies in brain cancer treatment.
Related Concept Videos
TGF - β Signaling Pathway
Mitogens and the Cell Cycle
Regulation of Angiogenesis and Blood Supply
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...

